Single-crystalline twelve-connected nanographene-based covalent organic frameworks expand reticular chemistry complexity
By
Omar M. Yaghi
Summary
This article reports the design and synthesis of single-crystalline twelve-connected nanographene-based covalent organic frameworks (COFs), representing a significant expansion of reticular chemistry into more complex architectures. The research demonstrates the precise translation of molecular geometry into extended crystalline frameworks using nanographene building blocks with twelve connectivity points, achieving highly ordered porous structures. This work pushes the boundaries of framework complexity in COF chemistry.
Source
Twitter / XSingle-crystalline twelve-connected nanographene-based covalent organic frameworks expand reticular chemistry complexitygo.acs.orgKey quotes
· 3 pulledThe expansion of reticular chemistry into increasingly complex architectures relies on the precise translation of molecular geometry into extended crystalline frameworks.
Here, we report the design...
ACS Editors' Choice® is a collection designed to feature scientific articles of broad public interest.
You might also wanna read
Atomically precise carbon structure fabrication demonstrated using inverted-mode STM mechanosynthesis
Researchers demonstrate atomically precise mechanosynthesis of carbon structures on a hydrogen-passivated Si(100) surface using inverted-mod
arxiv.org·1mo ago
New iron-based MOF captures CO₂ from flue gas and converts it to CO using light
Researchers from City University of Hong Kong and USTC have developed a new family of iron-based metal–organic frameworks (MOFs) that can bo
chemistryviews.org·4d ago
Athermally photoreduced graphene oxides for three-dimensional holographic images - Nature Communications
Nobel Prize in Chemistry 2025 Awarded for Development of Metal-Organic Frameworks
The 2025 Nobel Prize in Chemistry was awarded to Susumu Kitagawa, Richard Robson, and Omar M. Yaghi for their development of metal-organic f
nobelprize.org·8mo ago
Facilitating structure-based drug discovery with an artificial intelligence-driven virtual screening platform
Comments
Sign in to join the conversation.
No comments yet. Be the first.